NasdaqCM - Delayed Quote • USD
Cryoport, Inc. (CYRX)
At close: April 25 at 4:00 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 9 | 9 | 9 | 8 |
Avg. Estimate | -0.35 | -0.33 | -1.3 | -1 |
Low Estimate | -0.42 | -0.41 | -1.62 | -1.4 |
High Estimate | -0.19 | -0.15 | -0.58 | -0.3 |
Year Ago EPS | -0.16 | -0.42 | -2.21 | -1.3 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 8 | 8 | 9 | 8 |
Avg. Estimate | 58.76M | 60.29M | 245.68M | 272.21M |
Low Estimate | 56.6M | 57.4M | 242.6M | 263.93M |
High Estimate | 61.09M | 61.98M | 248.36M | 283.37M |
Year Ago Sales | 62.82M | 59.36M | 233.25M | 245.68M |
Sales Growth (year/est) | -6.50% | 1.60% | 5.30% | 10.80% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.19 | -0.24 | -0.3 | -0.29 |
EPS Actual | -0.16 | -0.42 | -0.31 | -1.31 |
Difference | 0.03 | -0.18 | -0.01 | -1.02 |
Surprise % | 15.80% | -75.00% | -3.30% | -351.70% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.35 | -0.33 | -1.3 | -1 |
7 Days Ago | -0.35 | -0.33 | -1.3 | -1 |
30 Days Ago | -0.35 | -0.33 | -1.3 | -0.95 |
60 Days Ago | -0.26 | -0.25 | -0.96 | -0.68 |
90 Days Ago | -0.27 | -0.26 | -0.98 | -0.68 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | 1 | -- | -- | -- |
Up Last 30 Days | 1 | -- | -- | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | CYRX | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -118.70% | -- | -- | 1.50% |
Next Qtr. | 21.40% | -- | -- | 12.10% |
Current Year | 41.20% | -- | -- | 4.40% |
Next Year | 23.10% | -- | -- | 13.20% |
Next 5 Years (per annum) | -- | -- | -- | 10.97% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | UBS: Neutral to Neutral | 3/15/2024 |
Reiterates | Stephens & Co.: Equal-Weight to Equal-Weight | 3/13/2024 |
Maintains | Needham: Buy to Buy | 3/13/2024 |
Maintains | Needham: Buy to Buy | 1/18/2024 |
Initiated | Morgan Stanley: Equal-Weight | 8/17/2023 |
Maintains | Needham: Buy to Buy | 8/10/2023 |